Shannon John Patrick Jr
Insider CIK 1553595 · XERS See Remarks · DRTX Chief Commercial Officer · XERS See Remarks, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| XERS Xeris Biopharma Holdings, | F Tax w/h | 2026-08-01 | 2026-08-21 | 36,645 | $8.08 | $296.1K | 2,898,933 | SEC↗ |
| XERS Xeris Biopharma Holdings, | F Tax w/h | 2026-08-01 | 2026-08-21 | 36,645 | $8.08 | $296.1K | 2,898,933 | SEC↗ |
| XERS Xeris Biopharma Holdings, | F Tax w/h | 2026-01-31 | 2026-02-02 | 118,134 | $7.36 | $869.5K | 3,157,949 | SEC↗ |
| XERS Xeris Biopharma Holdings, | F Tax w/h | 2026-01-31 | 2026-02-02 | 111,621 | $7.36 | $821.5K | 3,046,328 | SEC↗ |
| XERS Xeris Biopharma Holdings, | F Tax w/h | 2026-01-31 | 2026-02-02 | 110,750 | $7.36 | $815.1K | 2,935,578 | SEC↗ |
| XERS Xeris Biopharma Holdings, | A Award deriv | 2026-01-30 | 2026-02-02 | 639,639 | — | $0 | 639,639 | SEC↗ |
| XERS Xeris Biopharma Holdings, | A Award | 2026-01-30 | 2026-02-02 | 478,436 | — | $0 | 3,276,083 | SEC↗ |
| XERS Xeris Biopharma Holdings, | M Exercise deriv | 2026-01-05 | 2026-01-06 | 64,265 | — | $0 | 0 | SEC↗ |
| XERS Xeris Biopharma Holdings, | M Exercise deriv | 2026-01-05 | 2026-01-06 | 2,900 | — | $0 | 97,100 | SEC↗ |
| XERS Xeris Biopharma Holdings, | M Exercise deriv | 2026-01-05 | 2026-01-06 | 25,136 | — | $0 | 0 | SEC↗ |
| XERS Xeris Biopharma Holdings, | M Exercise | 2026-01-05 | 2026-01-06 | 64,265 | $1.55 | $99.6K | 2,769,611 | SEC↗ |
| XERS Xeris Biopharma Holdings, | M Exercise | 2026-01-05 | 2026-01-06 | 25,136 | $1.55 | $39.0K | 2,794,747 | SEC↗ |
| XERS Xeris Biopharma Holdings, | M Exercise | 2026-01-05 | 2026-01-06 | 2,900 | $3.94 | $11.4K | 2,797,647 | SEC↗ |
| XERS Xeris Biopharma Holdings, | S Sale | 2026-01-05 | 2026-01-06 | 24,907 | $7.08 | $176.3K | 2,705,346 | SEC↗ |
| XERS Xeris Biopharma Holdings, | M Exercise deriv | 2025-11-14 | 2025-11-17 | 87,100 | — | $0 | 64,265 | SEC↗ |
| XERS Xeris Biopharma Holdings, | M Exercise | 2025-11-14 | 2025-11-17 | 87,100 | $1.55 | $135.0K | 2,730,253 | SEC↗ |
| XERS Xeris Biopharma Holdings, | M Exercise deriv | 2025-11-13 | 2025-11-17 | 8,970 | — | $0 | 151,365 | SEC↗ |
| XERS Xeris Biopharma Holdings, | S Sale | 2025-11-13 | 2025-11-17 | 23,242 | $7.46 | $173.4K | 2,643,153 | SEC↗ |
| XERS Xeris Biopharma Holdings, | M Exercise | 2025-11-13 | 2025-11-17 | 8,970 | $1.55 | $13.9K | 2,666,395 | SEC↗ |
| XERS Xeris Biopharma Holdings, | F Tax w/h | 2025-08-01 | 2025-08-04 | 36,918 | $5.38 | $198.6K | 2,657,425 | SEC↗ |
| XERS Xeris Biopharma Holdings, | A Award deriv | 2025-01-31 | 2025-02-03 | 600,000 | — | $0 | 600,000 | SEC↗ |
| XERS Xeris Biopharma Holdings, | A Award | 2025-01-31 | 2025-02-03 | 800,000 | — | $0 | 2,687,118 | SEC↗ |
| XERS Xeris Biopharma Holdings, | F Tax w/h | 2025-01-31 | 2025-02-03 | 110,750 | $3.56 | $394.3K | 1,997,868 | SEC↗ |
| XERS Xeris Biopharma Holdings, | F Tax w/h | 2025-01-31 | 2025-02-03 | 110,750 | $3.56 | $394.3K | 1,887,118 | SEC↗ |
| XERS Xeris Biopharma Holdings, | F Tax w/h | 2025-01-03 | 2025-01-07 | 39,443 | $3.61 | $142.4K | 2,108,618 | SEC↗ |
| XERS Xeris Biopharma Holdings, | A Award deriv | 2024-08-01 | 2024-08-02 | 300,000 | — | $0 | 300,000 | SEC↗ |
| XERS Xeris Biopharma Holdings, | A Award | 2024-08-01 | 2024-08-02 | 250,000 | — | $0 | 2,419,612 | SEC↗ |
| XERS Xeris Biopharma Holdings, | F Tax w/h | 2024-01-31 | 2024-08-02 | 110,750 | $2.46 | $272.4K | 2,148,061 | SEC↗ |
| XERS Xeris Biopharma Holdings, | A Award | 2024-01-31 | 2024-01-31 | 750,000 | — | $0 | 2,158,575 | SEC↗ |
| XERS Xeris Biopharma Holdings, | F Tax w/h | 2024-01-29 | 2024-08-02 | 22,150 | $2.66 | $58.9K | 2,258,811 | SEC↗ |
| XERS Xeris Biopharma Holdings, | F Tax w/h | 2024-01-03 | 2024-08-02 | 40,834 | $2.24 | $91.5K | 2,280,961 | SEC↗ |
| XERS Xeris Biopharma Holdings, | P Buy | 2023-11-17 | 2023-11-17 | 30,769 | $1.64 | $50.5K | 1,408,575 | SEC↗ |
| XERS Xeris Biopharma Holdings, | F Tax w/h | 2023-01-31 | 2024-08-02 | 9,880 | $1.24 | $12.3K | 2,321,795 | SEC↗ |
| XERS Xeris Biopharma Holdings, | A Award | 2023-01-31 | 2023-02-01 | 750,000 | — | $0 | 1,377,806 | SEC↗ |
| XERS Xeris Biopharma Holdings, | F Tax w/h | 2023-01-29 | 2024-08-02 | 23,414 | $1.26 | $29.5K | 2,331,675 | SEC↗ |
| XERS Xeris Biopharma Holdings, | F Tax w/h | 2023-01-03 | 2024-08-02 | 41,334 | $1.12 | $46.3K | 2,355,089 | SEC↗ |
| XERS Xeris Biopharma Holdings, | F Tax w/h | 2022-01-31 | 2024-08-02 | 7,497 | $2.11 | $15.8K | 2,396,423 | SEC↗ |
| XERS Xeris Biopharma Holdings, | F Tax w/h | 2022-01-29 | 2024-08-02 | 15,692 | $2.11 | $33.1K | 2,403,920 | SEC↗ |
| XERS Xeris Biopharma Holdings, | A Award | 2022-01-03 | 2022-01-05 | 250,000 | — | $0 | 618,910 | SEC↗ |
| XERS Xeris Biopharma Holdings, | P Buy | 2021-11-12 | 2021-11-12 | 60,000 | $2.10 | $126.0K | 363,829 | SEC↗ |
| XERS Xeris Biopharma Holdings, | P Buy | 2021-11-11 | 2021-11-12 | 40,000 | $2.09 | $83.6K | 303,829 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | D To issuer deriv | 2021-10-05 | 2021-10-05 | 100,000 | — | $0 | 0 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | D To issuer deriv | 2021-10-05 | 2021-10-05 | 80,000 | — | $0 | 0 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | D To issuer deriv | 2021-10-05 | 2021-10-05 | 34,977 | — | $0 | 0 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | D To issuer deriv | 2021-10-05 | 2021-10-05 | 28,072 | — | $0 | 0 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | D To issuer deriv | 2021-10-05 | 2021-10-05 | 25,136 | — | $0 | 0 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | D To issuer deriv | 2021-10-05 | 2021-10-05 | 160,335 | — | $0 | 0 | SEC↗ |
| XERS Xeris Biopharma Holdings, | A Award deriv | 2021-10-05 | 2021-10-05 | 28,072 | — | $0 | 28,072 | SEC↗ |
| XERS Xeris Biopharma Holdings, | A Award deriv | 2021-10-05 | 2021-10-05 | 100,000 | — | $0 | 100,000 | SEC↗ |
| XERS Xeris Biopharma Holdings, | A Award deriv | 2021-10-05 | 2021-10-05 | 160,335 | — | $0 | 160,335 | SEC↗ |
| XERS Xeris Biopharma Holdings, | A Award deriv | 2021-10-05 | 2021-10-05 | 34,977 | — | $0 | 34,977 | SEC↗ |
| XERS Xeris Biopharma Holdings, | A Award deriv | 2021-10-05 | 2021-10-05 | 80,000 | — | $0 | 80,000 | SEC↗ |
| XERS Xeris Biopharma Holdings, | A Award deriv | 2021-10-05 | 2021-10-05 | 25,136 | — | $0 | 25,136 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | D To issuer | 2021-10-05 | 2021-10-05 | 193,333 | — | $0 | 0 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | D To issuer | 2021-10-05 | 2021-10-05 | 70,496 | — | $0 | 193,333 | SEC↗ |
| XERS Xeris Biopharma Holdings, | A Award | 2021-10-05 | 2021-10-05 | 193,333 | — | $0 | 263,829 | SEC↗ |
| XERS Xeris Biopharma Holdings, | A Award | 2021-10-05 | 2021-10-05 | 70,496 | — | $0 | 70,496 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | A Award | 2021-01-29 | 2021-02-01 | 150,000 | — | $0 | 271,224 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | A Award deriv | 2020-08-18 | 2020-08-20 | 100,000 | — | $0 | 100,000 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | A Award | 2020-06-30 | 2020-07-15 | 3,731 | $2.26 | $8.4K | 121,224 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | P Buy | 2020-05-13 | 2020-05-14 | 22,000 | $3.55 | $78.1K | 117,493 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | P Buy | 2020-05-08 | 2020-05-11 | 7,886 | $3.20 | $25.2K | 95,493 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | P Buy | 2020-02-14 | 2020-02-18 | 12,048 | $4.15 | $50.0K | 22,607 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | A Award | 2020-01-31 | 2020-03-02 | 65,000 | — | $0 | 87,607 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | A Award | 2019-12-31 | 2020-01-06 | 438 | $5.99 | $2.6K | 10,559 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | A Award | 2019-07-01 | 2019-07-03 | 1,138 | $9.72 | $11.1K | 10,121 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | A Award deriv | 2019-01-31 | 2019-02-01 | 80,000 | — | $0 | 80,000 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | C Conversion deriv | 2018-06-25 | 2018-06-27 | 16,000 | — | $0 | 0 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | C Conversion | 2018-06-25 | 2018-06-27 | 8,983 | — | $0 | 8,983 | SEC↗ |
| DRTX Durata Therapeutics, Inc. | D To issuer deriv | 2014-11-17 | 2014-11-18 | 20,000 | — | $0 | 0 | SEC↗ |
| DRTX Durata Therapeutics, Inc. | D To issuer deriv | 2014-11-17 | 2014-11-18 | 93,750 | — | $0 | 0 | SEC↗ |
| DRTX Durata Therapeutics, Inc. | D To issuer deriv | 2014-11-17 | 2014-11-18 | 75,000 | — | $0 | 0 | SEC↗ |
| DRTX Durata Therapeutics, Inc. | D To issuer | 2014-11-17 | 2014-11-18 | 11,000 | — | $0 | 0 | SEC↗ |
| DRTX Durata Therapeutics, Inc. | P Buy | 2014-08-12 | 2014-08-13 | 3,000 | $13.72 | $41.2K | 11,000 | SEC↗ |
| DRTX Durata Therapeutics, Inc. | A Award deriv | 2014-05-21 | 2014-05-22 | 75,000 | — | $0 | 188,750 | SEC↗ |
| DRTX Durata Therapeutics, Inc. | A Award deriv | 2013-02-12 | 2013-02-14 | 20,000 | $7.49 | $149.8K | 113,750 | SEC↗ |